Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
33
NCT04705844
Study of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19 (COMBAAT)
Phase: Phase 3
Role: Collaborator
Start: Sep 30, 2021
Completion: Sep 30, 2022
NCT05252910
Specimen Collection Study From Coronavirus Disease 2019 (COVID-19) Vaccinated Adults and Adolescents
Phase: N/A
Role: Lead Sponsor
Start: Jan 1, 2022
Completion: Mar 4, 2022